<DOC>
	<DOC>NCT00162058</DOC>
	<brief_summary>To determine the optimal dose of DMP 115 to image liver lesions and to assess whether contrast can improve the detection of focal liver lesions.</brief_summary>
	<brief_title>A Phase II Study of DMP 115 to Assess Focal Liver Lesions</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Diagnosed with 1 but &lt;7 focal liver lesions Scheduled for liver biopsy within 30 days of study Scheduled for CT or MR within 30 days of study Critically ill subjects Subjects with righttoleft shunts</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>